Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,745,404
  • Shares Outstanding, K 289,042
  • Annual Sales, $ 20,178 M
  • Annual Income, $ 1,726 M
  • EBIT $ 2,424 M
  • EBITDA $ 4,710 M
  • 60-Month Beta 0.43
  • Price/Sales 3.23
  • Price/Cash Flow 10.66
  • Price/Book 2.51

Options Overview Details

View History
  • Implied Volatility 16.67% ( +0.57%)
  • Historical Volatility 22.04%
  • IV Percentile 9%
  • IV Rank 9.15%
  • IV High 28.78% on 08/05/24
  • IV Low 15.45% on 08/30/24
  • Put/Call Vol Ratio 0.80
  • Today's Volume 236
  • Volume Avg (30-Day) 631
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 18,999
  • Open Int (30-Day) 18,590

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.97
  • Number of Estimates 9
  • High Estimate 3.00
  • Low Estimate 2.92
  • Prior Year 2.68
  • Growth Rate Est. (year over year) +10.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
220.54 +1.57%
on 11/19/24
244.33 -8.32%
on 11/06/24
-15.71 (-6.55%)
since 10/22/24
3-Month
220.54 +1.57%
on 11/19/24
244.98 -8.56%
on 09/03/24
-11.30 (-4.80%)
since 08/22/24
52-Week
218.75 +2.40%
on 07/10/24
249.89 -10.36%
on 01/09/24
-12.80 (-5.41%)
since 11/22/23

Most Recent Stories

More News
Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

XLV : 144.16 (+0.09%)
$SPX : 5,969.34 (+0.35%)
BDX : 224.00 (-0.64%)
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?

On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...

HOLX : 78.97 (+0.32%)
BDX : 224.00 (-0.64%)
QGEN : 42.78 (+1.06%)
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...

DGX : 163.59 (-0.18%)
BSX : 90.00 (-1.64%)
BDX : 224.00 (-0.64%)
RMD : 243.78 (+0.07%)
Becton Dickinson: Fiscal Q4 Earnings Snapshot

Becton Dickinson: Fiscal Q4 Earnings Snapshot

BDX : 224.00 (-0.64%)
Bear of the Day: Align Technology (ALGN)

Align Technology (ALGN) is a Zacks Rank #5 (Strong Sell) that is a global leader in digital orthodontics and the creator of the Invisalign clear aligner system.Align recently reported earnings, with an...

BDX : 224.00 (-0.64%)
ALGN : 225.89 (-1.02%)
Women in Canada Can Now Collect Their Own Sample at Home for Cervical Cancer Screening

/CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today Health Canada approval of the BD...

BDX : 224.00 (-0.64%)
Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

XLV : 144.16 (+0.09%)
$SPX : 5,969.34 (+0.35%)
BDX : 224.00 (-0.64%)
3 Dividend Kings To Buy and Hold in Your Forever Portfolio

These three companies are top choices for a dividend-growth portfolio.

BDX : 224.00 (-0.64%)
TNC : 89.69 (+2.05%)
PH : 706.87 (+0.60%)
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research

Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation...

BSX : 90.00 (-1.64%)
BDX : 224.00 (-0.64%)
BAX : 33.21 (+0.67%)
DVA : 165.51 (+0.83%)
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

Following a slump, shares of Medtronic MDT seem to have started to recuperate, possibly banking on a gradually improving investment and research scenario, thanks to the recent monetary policy easing. Closing...

ABT : 117.76 (+0.43%)
BSX : 90.00 (-1.64%)
BDX : 224.00 (-0.64%)
MDT : 86.21 (+1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 228.89
2nd Resistance Point 227.57
1st Resistance Point 225.78
Last Price 224.00
1st Support Level 222.67
2nd Support Level 221.35
3rd Support Level 219.56

See More

52-Week High 249.89
Fibonacci 61.8% 237.99
Fibonacci 50% 234.32
Fibonacci 38.2% 230.65
Last Price 224.00
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar